UnitedHealth Group (UNH) is a $294.2 billion diversified health care company, operating in the U.S. and internationally through various segments. Analysts predict a 69.3% drop in adjusted EPS for Q4 2025, but anticipate nearly 8% growth for fiscal 2026. UNH stock has dipped 35.9% in the past year.

Despite weak Q3 2025 revenue, UnitedHealth Group saw a rise in shares after beating EPS estimates. The company raised its 2025 profit forecast and is focused on cost stabilization. Analysts rate UNH stock as “Moderate Buy,” with an average price target of $394.91, indicating a potential upside of 21.6%.

Read more at Yahoo Finance: What To Expect From UnitedHealth’s Report